Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094395093> ?p ?o ?g. }
- W2094395093 endingPage "3551" @default.
- W2094395093 startingPage "3541" @default.
- W2094395093 abstract "Abstract Purpose: Transcription factor RUNX1 is essential for normal hematopoiesis. High mutation frequencies of RUNX1 gene in chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) have been described, whereas the biologic significances of the mutations were not investigated. Here, we aimed to correlate the biologic activities of the RUNX1 mutants with the clinical outcomes of patients. Experimental Design: We examined the mutational status of RUNX1 in 143 MDS and 84 CMML patients. Then, we studied the DNA and CBFβ binding abilities of all the RUNX1 mutants identified by using electrophoretic mobility shift assay and co-immunoprecipitation assay, and also determined their activities on target C-FMS gene induction by Western blotting and luciferase reporter assay. Using luciferase reporter assay, the relative biologic activities of each RUNX1 mutant could be quantified and correlated with the patient outcomes by statistical analyses. Results: We observed that most RUNX1 mutants had reduced abilities in DNA binding, CBFβ heterodimerization, and C-FMS gene induction. The relative biologic activities of RUNX1 mutants were grouped into high- and low-activity mutations. Correlation of the activities of RUNX1 mutants with the clinical outcomes revealed that patients harboring lower activities of RUNX1 mutants had a higher risk and shorter time to secondary acute myeloid leukemia transformation in MDS and CMML. In multivariate analysis, low RUNX1 activity remained an independent predictor for secondary acute myeloid leukemia–free survival in MDS patients. Conclusions: The biologic activity rather than the mutational status of RUNX1 might be an indicator in predicting outcome of patients with MDS and CMML. Clin Cancer Res; 21(15); 3541–51. ©2015 AACR." @default.
- W2094395093 created "2016-06-24" @default.
- W2094395093 creator A5003872931 @default.
- W2094395093 creator A5008211573 @default.
- W2094395093 creator A5018952988 @default.
- W2094395093 creator A5025341554 @default.
- W2094395093 creator A5043803592 @default.
- W2094395093 creator A5047371104 @default.
- W2094395093 creator A5048019679 @default.
- W2094395093 creator A5048883888 @default.
- W2094395093 creator A5060550601 @default.
- W2094395093 creator A5063094149 @default.
- W2094395093 date "2015-08-01" @default.
- W2094395093 modified "2023-10-18" @default.
- W2094395093 title "Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes" @default.
- W2094395093 cites W1489375841 @default.
- W2094395093 cites W15248648 @default.
- W2094395093 cites W1541919983 @default.
- W2094395093 cites W1600695244 @default.
- W2094395093 cites W1739103212 @default.
- W2094395093 cites W1965200529 @default.
- W2094395093 cites W1978135986 @default.
- W2094395093 cites W1986389204 @default.
- W2094395093 cites W1998460742 @default.
- W2094395093 cites W1998480851 @default.
- W2094395093 cites W2012897051 @default.
- W2094395093 cites W2015157349 @default.
- W2094395093 cites W2035543326 @default.
- W2094395093 cites W2037573449 @default.
- W2094395093 cites W2039409359 @default.
- W2094395093 cites W2056560239 @default.
- W2094395093 cites W2079677342 @default.
- W2094395093 cites W2080607444 @default.
- W2094395093 cites W2085033687 @default.
- W2094395093 cites W2090915512 @default.
- W2094395093 cites W2091814813 @default.
- W2094395093 cites W2101518963 @default.
- W2094395093 cites W2103012849 @default.
- W2094395093 cites W2107900913 @default.
- W2094395093 cites W2148033929 @default.
- W2094395093 cites W2149787089 @default.
- W2094395093 cites W2151958425 @default.
- W2094395093 cites W2162544653 @default.
- W2094395093 cites W2165787335 @default.
- W2094395093 cites W4231034519 @default.
- W2094395093 doi "https://doi.org/10.1158/1078-0432.ccr-14-2203" @default.
- W2094395093 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25840971" @default.
- W2094395093 hasPublicationYear "2015" @default.
- W2094395093 type Work @default.
- W2094395093 sameAs 2094395093 @default.
- W2094395093 citedByCount "47" @default.
- W2094395093 countsByYear W20943950932016 @default.
- W2094395093 countsByYear W20943950932017 @default.
- W2094395093 countsByYear W20943950932018 @default.
- W2094395093 countsByYear W20943950932019 @default.
- W2094395093 countsByYear W20943950932020 @default.
- W2094395093 countsByYear W20943950932021 @default.
- W2094395093 countsByYear W20943950932022 @default.
- W2094395093 countsByYear W20943950932023 @default.
- W2094395093 crossrefType "journal-article" @default.
- W2094395093 hasAuthorship W2094395093A5003872931 @default.
- W2094395093 hasAuthorship W2094395093A5008211573 @default.
- W2094395093 hasAuthorship W2094395093A5018952988 @default.
- W2094395093 hasAuthorship W2094395093A5025341554 @default.
- W2094395093 hasAuthorship W2094395093A5043803592 @default.
- W2094395093 hasAuthorship W2094395093A5047371104 @default.
- W2094395093 hasAuthorship W2094395093A5048019679 @default.
- W2094395093 hasAuthorship W2094395093A5048883888 @default.
- W2094395093 hasAuthorship W2094395093A5060550601 @default.
- W2094395093 hasAuthorship W2094395093A5063094149 @default.
- W2094395093 hasBestOaLocation W20943950932 @default.
- W2094395093 hasConcept C104317684 @default.
- W2094395093 hasConcept C126322002 @default.
- W2094395093 hasConcept C143065580 @default.
- W2094395093 hasConcept C2777928532 @default.
- W2094395093 hasConcept C2778193527 @default.
- W2094395093 hasConcept C2778461978 @default.
- W2094395093 hasConcept C2778729363 @default.
- W2094395093 hasConcept C2779282312 @default.
- W2094395093 hasConcept C2780007613 @default.
- W2094395093 hasConcept C2780817109 @default.
- W2094395093 hasConcept C501734568 @default.
- W2094395093 hasConcept C502942594 @default.
- W2094395093 hasConcept C54355233 @default.
- W2094395093 hasConcept C71924100 @default.
- W2094395093 hasConcept C86339819 @default.
- W2094395093 hasConcept C86803240 @default.
- W2094395093 hasConceptScore W2094395093C104317684 @default.
- W2094395093 hasConceptScore W2094395093C126322002 @default.
- W2094395093 hasConceptScore W2094395093C143065580 @default.
- W2094395093 hasConceptScore W2094395093C2777928532 @default.
- W2094395093 hasConceptScore W2094395093C2778193527 @default.
- W2094395093 hasConceptScore W2094395093C2778461978 @default.
- W2094395093 hasConceptScore W2094395093C2778729363 @default.
- W2094395093 hasConceptScore W2094395093C2779282312 @default.
- W2094395093 hasConceptScore W2094395093C2780007613 @default.
- W2094395093 hasConceptScore W2094395093C2780817109 @default.
- W2094395093 hasConceptScore W2094395093C501734568 @default.